Clinical Trials

NCT IdNCT04107168
TitleMicrobiome Immunotherapy Toxicity and Response Evaluation
ConditionMelanoma
StudyTypeObservational
OrganizationCambridge University Hospitals NHS Foundation Trust
Sponsor/CollaboratorsCCTU- Cancer Theme
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ , United Kingdom
DescriptionThis is a observational study to investigate how the microbiome correlates with efficacy and toxicity of immune checkpoint inhibitors in patients with advanced cancer.